期刊文献+

组蛋白乙酰化酶和去乙酰化酶对心脏发育影响的研究进展 被引量:3

下载PDF
导出
摘要 心脏发育受遗传和环境双重影响,任何微小的病变都会导致心脏发育异常,但潜在的机制仍不清楚.心脏发育相关基因的顺序表达是构建完美心脏的生物学基础.随着分子生物学技术的发展,人们逐渐意识到环境因素对心脏发育影响的重要性.表观遗传学的提出为心脏发育异常的研究带来了新的契机.
作者 彭昌 田杰
出处 《广东医学》 CAS CSCD 北大核心 2013年第24期3818-3820,共3页 Guangdong Medical Journal
基金 国家自然科学基金资助项目(编号:81270234) 重庆市重点实验室专项经费自主科研课题
  • 相关文献

参考文献35

  • 1KIM G H,RYAN J J,ARCHER S L. The role of redox signaling in epigenetics and cardiovascular disease[J].{H}Antioxidants and Redox Signaling,2013,(15):1920-1936.
  • 2SADOUL K,BOYAULT C,PABION M. Regulation of protein turnover by acetyltransferases and deacetylases[J].{H}Biochimime,2008,(02):306-312.doi:10.1016/j.biochi.2007.06.009.
  • 3CLAYTON A L,HAZZALIN C A,MAHADEVAN L C. Enhanced histone acetylation and transcription:a dynamic perspective[J].{H}Molecules and Cells,2006,(03):289-296.
  • 4常锐,尤嘉琮,周清华.HATs与HDACs在肺癌上皮细胞间质转化中作用机制及其应用的研究进展[J].中国肺癌杂志,2013,16(4):211-215. 被引量:5
  • 5YANG X J,SETO E. HATs and HDACs:from structure,function and regulation to novel strategies for therapy and prevention[J].{H}ONCOGENE,2007,(37):5310-5318.
  • 6MUJTABA S,ZENG L,ZHOU M M. Structure and acetyl-lysine recognition of the bromodomain[J].{H}ONCOGENE,2007,(37):5521-5527.
  • 7LIN W,SRAJER G,EVRARD Y A. Developmental potential of Gcn5-/-embryonic stem cells in vivo and in vitro[J].{H}Development Dynamics,2007,(06):1547-1557.
  • 8WITT O,DEUBZER H E,MILDE T. HDAC family:What are the cancer relevant targets[J].{H}CANCER LETTERS,2009,(01):8-21.
  • 9GOVINDARAJAN N,RAO P,BURKHARDT S. Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer's disease[J].EMBO Mol Med,2013,(01):52-63.
  • 10WATERS L,YUE B,VEVERKA V. Structural diversity in p160/CREB-binding protein coactivator complexes[J].{H}Journal of Biological Chemistry,2006,(21):14787-14795.

二级参考文献32

  • 1Pena C, GarciaJM, Garcia V, et al. The expression levels of the transcriptional regulators p300 and CtBP modulate the correlations between SNAIL, ZEB1, E-cadherin and vitamin D receptor in human colon carcinomas. IntJ Cancer, 2006, 119(9): 2098-2104.
  • 2Yokomizo C, Yamaguchi K, Itoh Y, et al. High expression of p300 in HCC predicts shortened overall survival in association with enhanced epithelial mesenchymal transition of HCC cells. Cancer Lett, 2011, 310(2): 140-147.
  • 3Hsu YL Huang MS Yang CJj et al. Lung tumor-associated osteoblast- derived bone morphogenetic protein-2 increased epithelial-to-mesenchymal transition of cancer by Runx2/Snail signaling pathway. J Biol Chem, 2011, 286(43): 3733S-37346.
  • 4Mu Y, Sundar R, Thakur N, et al. TRAF6 ubiquitinates TGFbeta type I re- ceptor to promote its cleavage and nuclear translocation in cancer. Nat Com- mun, 2011, 2: 330.
  • 5Hamamori Y, Sartorelli V Ogryzko V, et al. Regulation ofhistone acetyltrans- ferases p300 and PCAF by the bHLH protein twist and adenoviral oncopro- rein E1A. Cell, 1999, 96(3): 405-413.
  • 6Postigo AA, Depp JL, Taylor JJ, et al. Regulation of Smad signaling through a differential recruitment of coactivators and corepressors by ZEB proteins. EMBO J, 2003, 22(10): 2453-2462.
  • 7Liu YN, Lee WW, Wang CY, et al. Regulatory mechanisms controlling hu- man E-cadherin gene expression. Oncogene, 2005, 24(56): 8277-8290.
  • 8Shiota M, Yokomizo A, Tada Y, et al. P300/CBP-associated factor regulates Y-box binding protein-1 expression and promotes cancer cell growth, cancer invasion and drug resistance. Cancer Sci, 2010, 101 (8): 1797-1806.
  • 9Mizuguchi Y, Specht S, Lunz JG, et al. Cooperation of p300 and PCAF in the control of microRNA 200c/141 transcription and epithelial characteristics. PLoS One, 2012, 7(2): e32449.
  • 10Akirnaru H, Hou DX, Ishii S. Drosophila CBP is required for dorsal-depen- dent twist gene expression. Nat Genet, 1997 17(2): 211-214.

共引文献4

同被引文献23

  • 1Gong F, Miller KM. Mammalian DNA repair: HATs and HDACs make their mark through histone aeetylation [ J ] ~ Murat Res, 2013,750(1-2) :23-30.
  • 2Stafford JM, Raybuck JD, Ryabinin AE, et al. Increasing histone acetylatian it~ the hippocampus-infralimbic network enhances fear extinction [ J ]. Biol Psychiatry ,2012,72 ( 1 ) :25-33.
  • 3Deubzer HE,Schier MC, Oehme I, et al. HDACI 1 is a novel drug target in carcinomas [ J ]. Int J Cancer,2013,132 (9) :2200-2208.
  • 4Dent P. HDACIs and the inhibition of invasive potential[ J]. Canc- er Biol Ther,2013,14 ( 9 ) :776-777.
  • 5Wong A, Young B. The Future is Now: Frontiers on Display at Yale-NAVBO Cardiovascular Inflammation and Remodeling Sym- posium[ J]. Yale J Biol Med ,2014,87 (4) :593-599.
  • 6McKinsey TA. Targeting Inflammation in Heart Failure with Histone Deacetylase Inhibitors [ J ]. Mol Med,2011,17 (5-6) :434-441.
  • 7Nural-Guvener HF,Zakharova L,Nimlos J,et al. HDAC class I in-hihitor, Mocetinostat, reverses cardiac fiborsis in heart failure and diminishes CD90 + cardiac myofibmblast activation [ J]. Fibrogen- esis Tissue Repair,2014,7 (2) : 10.
  • 8Chen W, Frangogiannis NG. Fibroblasts in post-infarction inflam- mation and cardiac repair[ J]. Biochim Biophys Acta,2013,1833 (4) :945-953.
  • 9Madamanchi NR, Runge MS. Redox signaling in cardiovascular health and disease [ J ]. Free Radic Biol Med ,2013,61 ( 9 ) :473- 501.
  • 10Bradner JE, West N, Grachan ML, et al. Chemical phylogenetics of histone deacetylases [ J ]. Nat Chem Biol, 2010,6 ( 3 ) : 238- 243.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部